Moderna Inc

Novavax confident Covid vaccine will receive FDA authorization in June after delays

U.S. will limit next-generation Covid vaccines to high-risk people this fall if Congress doesn’t approve more funding

Kevin O’Leary says there are plenty of good places to ‘hide’ as interest rates rise

Stocks making the biggest moves midday: Uber, Lyft, Airbnb, Starbucks and more

Stocks making the biggest moves premarket: Uber, Brinker, Generac and more

5 things to know before the stock market opens Monday

Stocks making the biggest moves in the premarket: Activision Blizzard, Bilibili, Moody’s and more

Time for a fourth Covid vaccine dose? Here’s why medical professionals are skeptical

Moderna says its vaccine for ages under 6 will be ready for U.S. review in June

FDA panel to discuss Novavax Covid vaccine for adults, Pfizer and Moderna shots for kids in June